Editorial

DOI: 10.4244/EIJ-E-24-00015

When can we discharge patients after chronic total occlusion percutaneous coronary intervention?

William L. Lombardi1, MD; Lorenzo Azzalini1, MD, MSc, PhD

Implementing same-day discharge (SDD) after elective percutaneous coronary intervention (PCI) is associated with important cost savings1 and might also improve patient flow through the hospital. SDD has been steadily growing in certain environments (e.g., approximately one-third of elective PCIs in the USA in 20172), in parallel with the adoption of radial access12. The introduction of SDD has not correlated with worse overall clinical outcomes12, indicating its safety in specific scenarios. There seems to be a large between-hospital variation in SDD rates12, suggesting the existence of logistical and clinical practice-related barriers to a homogeneous adoption of SDD.

Chronic total occlusion (CTO) PCI has witnessed a remarkable growth over the past decade. Implementing an SDD strategy after CTO PCI is appealing for the same reasons as after PCI in all-comers, yet its implementation is hampered by unique challenges, including higher use of femoral access, contrast volume, and risk of procedural complications.

Small single-centre studies from the USA3 and Greece4 recently reported on the feasibility of SDD after CTO PCI. SDD was adopted in 41.7%...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 10
May 20, 2024
Volume 20 Number 10
View full issue


Key metrics

Suggested by Cory

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free

Feb 21, 2011
Tools & Techniques: PCI for acute MI tips and tricks
Dudek D et al
free

CLINICAL RESEARCH

10.4244/EIJV11I14A315 Apr 8, 2016
Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study
Farooq V et al
free

Editorial

10.4244/EIJ-E-23-00004 Mar 20, 2023
Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial
Lansky AJ and Ahmad Y
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved